1. Long term oral contraceptive use and the `silent thief of sight'

   News item 30 November 2013 Pages: 1 - 1

2. Potential rhabdomyolysis signal with mirtazapine

   Incidence study 30 November 2013 Pages: 2 - 2

3. Bisphosphonates may cause blurred vision

   Incidence study 30 November 2013 Pages: 2 - 2

4. Clinical development of fedratinib discontinued

   Media release 30 November 2013 Pages: 2 - 2

5. Post-immunisation risk of apnoea in preterm infants

   Incidence study 30 November 2013 Pages: 3 - 3

6. No new safety concerns for Roche products following inspection

   News item 30 November 2013 Pages: 3 - 3

7. 3rd & 4th gen oral contraceptives: risk factors and media hype

   News item 30 November 2013 Pages: 3 - 3

8. Increase in reports of long-term fatigue with Cervarix in girls

   Incidence study 30 November 2013 Pages: 4 - 4

9. Warning against clarithromycin, Ca-channel blocker coprescription

   Epidemiology population study 30 November 2013 Pages: 4 - 4

10. No increased risk of depression with varenicline, bupropion

    Epidemiology population study 30 November 2013 Pages: 4 - 4

11. Egyptian PV center recalls pizotifen syrup products

    News item 30 November 2013 Pages: 4 - 4

12. Alendronic acid

    Case report 30 November 2013 Pages: 5 - 5

13. Aciclovir

    Case report 30 November 2013 Pages: 5 - 5

14. Adalimumab

    Case report 30 November 2013 Pages: 5 - 5

15. Adalimumab

    Case report 30 November 2013 Pages: 5 - 5

16. Amitriptyline/atomoxetine/lisdexamfetamine

    Case report 30 November 2013 Pages: 6 - 6

17. Amiodarone/methotrexate

    Case report 30 November 2013 Pages: 6 - 6

18. Allopurinol

    Case report 30 November 2013 Pages: 6 - 6

19. Amlodipine/doxepin/prothipendyl interaction

    Case report 30 November 2013 Pages: 7 - 7

20. Amoxicillin

    Case report 30 November 2013 Pages: 7 - 7

21. Antineoplastics/oxycodone/paracetamol

    Case report 30 November 2013 Pages: 7 - 7

22. Artemisinin

    Case report 30 November 2013 Pages: 7 - 7

23. Amoxicillin/clavulanic acid

    Case report 30 November 2013 Pages: 7 - 7

24. Asparaginase/pegaspargase

    Case report 30 November 2013 Pages: 8 - 8

25. Atorvastatin

    Case report 30 November 2013 Pages: 8 - 8

26. Aspirin/heparin/sirolimus

    Case report 30 November 2013 Pages: 8 - 8

27. Atazanavir

    Case report 30 November 2013 Pages: 8 - 8

28. Atorvastatin

    Case report 30 November 2013 Pages: 9 - 9

29. Azathioprine

    Case report 30 November 2013 Pages: 9 - 9

30. Bevacizumab/triamcinolone

    Case report 30 November 2013 Pages: 9 - 9

31. Balsalazide

    Case report 30 November 2013 Pages: 9 - 9

32. Azithromycin

    Case report 30 November 2013 Pages: 9 - 9

33. Bleomycin

    Case report 30 November 2013 Pages: 10 - 10

34. Bumetanide

    Case report 30 November 2013 Pages: 10 - 10

35. Boceprevir/peginterferon-α-2a/ribavirin

    Case report 30 November 2013 Pages: 10 - 10

36. Botulinum toxin A

    Case report 30 November 2013 Pages: 10 - 10

37. Capecitabine/gemcitabine/ixabepilone

    Case report 30 November 2013 Pages: 11 - 11

38. Buprenorphine/pheniramine abuse

    Case report 30 November 2013 Pages: 11 - 11

39. Capecitabine/trastuzumab

    Case report 30 November 2013 Pages: 11 - 11

40. Carboplatin/etoposide

    Case report 30 November 2013 Pages: 12 - 12

41. Carboplatin/paclitaxel

    Case report 30 November 2013 Pages: 12 - 12

42. Carperitide/milrinone/sildenafil interaction

    Case report 30 November 2013 Pages: 12 - 12

43. Ciclosporin/icodextrin

    Case report 30 November 2013 Pages: 13 - 13

44. Carvedilol

    Case report 30 November 2013 Pages: 13 - 13

45. Clindamycin/gentamicin

    Case report 30 November 2013 Pages: 13 - 13

46. Cimicifuga

    Case report 30 November 2013 Pages: 13 - 13

47. Clozapine

    Case report 30 November 2013 Pages: 14 - 14

48. Clomipramine

    Case report 30 November 2013 Pages: 14 - 14

49. Cotrimoxazole

    Case report 30 November 2013 Pages: 14 - 14

50. Cortisone/hydrocortisone

    Case report 30 November 2013 Pages: 14 - 14